Efficacy and safety of ultra-low dose inhaled melphalan in the treatment of hospitalized patients with COVID-19

Efficacy and safety of ultra-low dose inhaled melphalan in the treatment of hospitalized patients with COVID-19

Background. One of the most important components of COVID-19 therapy is the suppression of the hyperergic immune response. There is an urgent need of creating the optimal tactics of efficient and safe anti-inflammatory therapy. A new method of treatment of COVID-19 with inhalation of ultra-low (non-...

Full description

Bibliographic Details
Main Authors: E. A. Sinitsyn, A. A. Zykova, R. V. Shamin, A. V. Rvacheva, A. O. Bogatyreva, T. V. Shapovalenko, G. G. Maryin, K. A. Zykov
Format: Article
Language:Russian
Published: Scientific Сentre for Family Health and Human Reproduction Problems 2022-05-01
Series:Acta Biomedica Scientifica
Subjects:
covid-19
alkylating drugs
treatment
melphalan
inhalations
inflammation
the who ordinal scale for clinical improvement
borg scale
Online Access:https://www.actabiomedica.ru/jour/article/view/3408

Internet

https://www.actabiomedica.ru/jour/article/view/3408

Similar Items